On the public citation graph
The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases
0 signed · 45 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/0887-8994(91)90099-7openalex-snapshot
Home use of rectal diazepam for cluster and prolonged seizures: Efficacy, adverse reactions, quality of life, and cost analysis
inferredcites →https://doi.org/10.1016/j.ddstr.2011.10.002openalex-snapshot
Drug repurposing from an academic perspective
inferredcites →https://doi.org/10.1016/s0140-6736(08)60872-7openalex-snapshot
Why rare diseases are an important medical and social issue
inferredcites →https://doi.org/10.1016/s1359-6446(02)02554-0openalex-snapshot
Cervical dysplasia: encapsulated DNA treatment shows promise
inferredcites →https://doi.org/10.1038/472019aopenalex-snapshot
Bulgarian funding agency accused of poor practice
inferredcites →https://doi.org/10.1038/nm1211-1525openalex-snapshot
Trial networks move beyond single-disease strategies
inferredcites →https://doi.org/10.1038/nmat1790openalex-snapshot
University spin-offs: Opportunity or challenge?
inferredcites →https://doi.org/10.1038/nrd3160openalex-snapshot
Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years
inferredcites →https://doi.org/10.1038/nrd3595openalex-snapshot
Clinical pharmacology as a cornerstone of orphan drug development
inferredcites →https://doi.org/10.1056/nejm199806253382602openalex-snapshot
A Comparison of Rectal Diazepam Gel and Placebo for Acute Repetitive Seizures
inferredcites →https://doi.org/10.1056/nejmsa1008268openalex-snapshot
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines
inferredcites →https://doi.org/10.1093/bib/bbr021openalex-snapshot
Drug repositioning for orphan diseases
inferredcites →https://doi.org/10.1111/j.1528-1157.1998.tb01415.xopenalex-snapshot
A Single‐Blind, Crossover Comparison of the Pharmacokinetics and Cognitive Effects of a New Diazepam Rectal Gel with Intravenous Diazepam
inferredcites →https://doi.org/10.1126/scitranslmed.3001512openalex-snapshot
The Emergence of Genome-Based Drug Repositioning
inferredcites →https://doi.org/10.1182/blood-2011-01-329235openalex-snapshot
Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report
inferredcites →https://doi.org/10.1542/peds.2011-1798openalex-snapshot
What the Orphan Drug Act Has Done Lately for Children With Rare Diseases: A 10-Year Analysis
inferredcites →https://doi.org/10.4103/0022-3859.81870openalex-snapshot
Drug repositioning: Re-investigating existing drugs for new therapeutic indications
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4816245openalex-extracted
On Quality Standards and the Timing of Pharmaceutical Investment
inferred← citeshttps://doi.org/10.1002/jbmr.2468openalex-snapshot
Repositioning Potential of PAK4 to Osteoclastic Bone Resorption
inferred← citeshttps://doi.org/10.1007/s10354-015-0423-0openalex-snapshot
Orphan diseases: state of the drug discovery art
inferred← citeshttps://doi.org/10.1016/b978-0-12-804066-9.00006-7openalex-snapshot
Regulatory Aspects for Drug Development
inferred← citeshttps://doi.org/10.1016/b978-1-60805-865-5.50002-2openalex-snapshot
Knowledge-Based Drug Repurposing: A Rational Approach Towards the Identification of Novel Medical Applications of Known Drugs
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.05.014openalex-snapshot
NIPTE: a multi-university partnership supporting academic drug development
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.04.016openalex-snapshot
Development of cell therapy medicinal products by academic institutes
inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104672openalex-snapshot
National differences in drug discovery and the role of startups: Insights from cross-national analysis of Phase III candidates
inferred← citeshttps://doi.org/10.1016/j.jaad.2019.05.025openalex-snapshot
The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers
inferred← citeshttps://doi.org/10.1021/bk-2012-1110.ch009openalex-snapshot
Preparing To Support Research Data Sharing
inferred← citeshttps://doi.org/10.1038/s41436-019-0616-9openalex-snapshot
Developing interactions with industry in rare diseases: lessons learned and continuing challenges
inferred← citeshttps://doi.org/10.1080/01900692.2016.1247367openalex-snapshot
Spurring Vaccine Development for the Developing World: A Collaborative Governance Perspective on Product Development Partnerships
inferred← citeshttps://doi.org/10.1080/08989621.2013.793120openalex-snapshot
When Everyone Is an Orphan: Against Adopting a U.S.-Styled Orphan Drug Policy in Canada
inferred← citeshttps://doi.org/10.1111/bcp.12776openalex-snapshot
A quarter century of progress in paediatric clinical pharmacology: A personal view
inferred← citeshttps://doi.org/10.1111/imr.12244openalex-snapshot
Targeting protein–protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
inferred← citeshttps://doi.org/10.11606/t.76.2015.tde-02102015-093453openalex-snapshot
Estudos estruturais e de química medicinal aplicados às enzimas da via glicolítica de protozoários: enolase de Plasmodium falciparum e gliceraldeído-3-fosfato desidrogenase de Trypanosoma cruzi
inferred← citeshttps://doi.org/10.1371/journal.pntd.0011760openalex-snapshot
Public-private partnerships influencing the initiation and duration of clinical trials for neglected tropical diseases
inferred← citeshttps://doi.org/10.21423/jrs-v04n03p007openalex-snapshot
Emerging Growth of Orphan Drugs for Neurological Diseases in Japan: Potential Benefits for Both Patients and Pharmaceutical Companies
inferred← citeshttps://doi.org/10.2147/dddt.s46289openalex-snapshot
Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases
inferred← citeshttps://doi.org/10.2478/dim-2021-0007openalex-snapshot
Discovering Booming Bio-entities and Their Relationship with Funds
inferred← citeshttps://doi.org/10.29014/ns.2023.27.97.2openalex-snapshot
Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1738084openalex-snapshot
On quality standards and the timing of pharmaceutical investment
inferred← citeshttps://doi.org/10.3390/children4080068openalex-snapshot
Key Challenges in the Search for Innovative Drug Treatments for Special Populations. Converging Needs in Neonatology, Pediatrics, and Medical Genetics
inferred← citeshttps://doi.org/10.35537/10915/43315openalex-snapshot
Búsqueda racional de nuevos fármacos antichagásicos inhibidores de la cruzipaína
inferred← citeshttps://doi.org/10.4155/fdd-2019-0006openalex-snapshot
Forward-Looking Perspective On Publishing in Drug Discovery
inferred← citeshttps://doi.org/10.4155/fmc.13.166openalex-snapshot
A Pharmacophore-Based Virtual Screening Approach for the Discovery of Trypanosoma Cruzi Gapdh Inhibitors
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.